Clinical trials: Immunization Coverage
Vaccination
Evaluation of a Tdap-IPV (Tetanus, Diphteria, Pertussis and Inactivated Polio) Vaccination Remedial Strategy on Vaccination Coverage in Patients 65 Years of Age or Older
In France, vaccination coverage is insufficient (in 2002, 71.2% coverage for tetanus, 41.9% for poliomyelitis and 33.7% for diphteria).
- Trial name
- HOSPIVAC (NCT03587610)
- Testing
- Remedial vaccination
- Where
- France
- Volunteers
- 218 people
- Sponsor
- Centre Hospitalier le Mans
Immunization; Infection
Evaluation of Conditional Cash Transfers (CCTs) for Immunization
Like many developing countries, Pakistan faces a public health challenge of low and incomplete immunization rates of children, only 54% of children aged 12 to 24 months are fully immunized, which leaves children susceptible to…
- Trial name
- NCT03355989
- Testing
- Conditional Cash Transfer, SMS Reminder
- Where
- Pakistan
- Volunteers
- 11,197 people, healthy volunteers welcome
- Sponsor
- Interactive Research and Development
Premature Birth
Evaluation of Immunization Coverage of Premature Infants Leaving CHU d'Angers According to the Recommended Regimen During the First 4 Months (VACCIPREM)
Premature children are particularly vulnerable in terms of infection and vaccinated in a specific, reinforced vaccination schedule.
- Trial name
- VACCIPREM (NCT03918096)
- Testing
- Questionnaire
- Where
- France
- Volunteers
- 384 people
- Sponsor
- University Hospital, Angers
Immunization Coverage, Breastfeeding
Testing Content Delivery Models for MomConnect
The case for mobile health (mHealth) has been gaining traction as a source to improve health outcomes of individuals. mHealth refers to the use of Information and Communication Technologies (ICT) to support health care.
- Conditions
- Immunization Coverage, Breastfeeding, Hematological Diseases
- Trial name
- MQR (NCT05505760)
- Testing
- Quality-Based Digital Messaging
- Where
- South Africa
- Volunteers
- 8,867 people
- Sponsor
- IDinsight
Plasmodium Falciparum Infection
PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States
This phase I trial of the replication-intact PfSPZ Challenge vaccine given under CQ cover will enroll 28 healthy volunteers to receive PfSPZ or placebo, as well as suppressive doses of chloroquine (CQ)on varying schedules.
- Trial name
- NCT02773979
- Testing
- Chloroquine, PfSPZ (NF54) Challenge
- Where
- United States
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Influenza, Vaccination Coverage
Communication Intervention to Improve Influenza Vaccination Rates Among Elderly in Can Tho
This study evaluates the effectiveness of a multi-component community-based communication intervention to increase influenza vaccination rates among adults aged above 65 years in Can Tho City, Vietnam.
- Conditions
- Influenza, Vaccination Coverage, Health Communication
- Trial name
- CIVECT (NCT07508189)
- Testing
- Multi-component Health Communication Package
- Where
- Vietnam
- Volunteers
- 1,237 people, healthy volunteers welcome
- Sponsor
- Can Tho University of Medicine and Pharmacy
Cirrhosis
Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021
the purpose of this study is to estimate vacinal coverage against hepatitis A and B viruses, pneumococcus, diphtheria/tetanos and poliomyelitis, influenza virus and covid in cirrhotic patients followed in general hospitals of…
- Trial name
- VACCIR (NCT04939350)
- Testing
- questionnaire
- Where
- France
- Volunteers
- 742 people
- Sponsor
- Centre Hospitalier Sud Francilien
Pneumococcal Infections
The Effect of AUDIT and Feedback on Pneumococcal Vaccination Coverage
The goal of this cluster-randomized trial is to study the effect of Audit and Feedback loops on pneumococcal vaccination coverage rate in adults at risk in general practice.
- Trial name
- NCT05920499
- Testing
- AUDIT and Feedback
- Where
- Belgium
- Volunteers
- 36 people
- Sponsor
- Bert Vaes
Human Papilloma Virus
Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
To determine if the emergency department (ED) setting offers a viable space for improving HPV vaccination coverage among 18 to 45-year-old adults who have not yet received human papilloma virus (HPV) vaccination or who did not…
- Trial name
- NCT06229353
- Testing
- Gardasil 9
- Where
- United States
- Volunteers
- 34 people, healthy volunteers welcome
- Sponsor
- University of Alabama at Birmingham
Diabetes
Vaccination Coverage in People Linving With Diabetes
For several years, the prevalence of people living with diabetes (pDT) has been steadily increasing. It was estimated by the health insurance in 2016 at 5 %, or more than 3.3 million people in France.
- Trial name
- VacDiab (NCT04391088)
- Testing
- vaccine coverage assessment
- Where
- France
- Volunteers
- 235 people
- Sponsor
- University Hospital, Montpellier
Cancer, HPV Associated Cancer
Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors
The primary objectives of this study are to increase HPV vaccination initiation and 3-dose completion among pediatric, adolescent, and young adult (PAYA) cancer survivors
- Trial name
- NCT05665543
- Testing
- GLAm app
- Where
- United States
- Volunteers
- 162 people
- Sponsor
- Masonic Cancer Center, University of Minnesota
Immunization Coverage, Vaccination
Increasing Measles Vaccination Coverage Through Supplementation With an SQ-LNS Incentive in Children Aged 6-23 Months
Provision of SQ-LNS also holds promise in incentivizing vaccination as well as other health services. The investigators will estimate 1) the effectiveness of a SQ-LNS mass supplementation program added to routine immunization…
- Conditions
- Immunization Coverage, Vaccination, Nutrition
- Trial name
- NCT06387511
- Testing
- Small-quantity lipid-based nutrition supplements (SQ-LNS) NutriVax, Sensitization on vaccination and on Infant and Young Child Feeding (IYCF) practices
- Where
- Nigeria
- Volunteers
- 3,814 people, healthy volunteers welcome
- Sponsor
- Alliance for International Medical Action
Incentives
Evaluating the Impact of Demand-Side Incentives (DSI) on Zero Dose Burden and Immunisation Coverage in Nigeria
The goal of this cluster Randomised Controlled Trial (cRCT) is to evaluate the impact and effectiveness of demand-side incentives (DSIs) in improving immunisation coverage and reducing the burden of zero-dose children between the…
- Trial name
- NCT06676787
- Testing
- Transportation Voucher, Comunity engagement and microplannnig support, Direct Facility Funding, Community Engagement, and Microplaning Support, Transportation Voucher, Direct Facility Funding, Community engagement and Microplanning support
- Where
- 2 sites in Nigeria
- Volunteers
- 115,589 people, healthy volunteers welcome
- Sponsor
- Corona Management Systems
Diphtheria, Tetanus
Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya
The project goal is to conduct a randomized controlled trial (RCT) to test whether mobile phone short message system (SMS) reminders, either with or without mobile-phone based travel subsidies will improve timeliness, coverage…
- Conditions
- Diphtheria, Tetanus, Pertussis, Hepatitis B
- Trial name
- m-SIMU (NCT01878435)
- Testing
- SMS reminder, Travel subsidy, Travel subsidy 2
- Where
- Kenya
- Volunteers
- 2,018 people, healthy volunteers welcome
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
COVID-19 Vaccines
Variables Influencing Anti-COVID-19 Vaccinations Around the World: an Analysis Conducted on Aggregated Data Sourced From Institutional Databases to Understand Whether and How Different Variables Could Affect the Vaccine Coverage (WORLDCOV: Worldwide Determinants of COVID-19 Vaccination)
Vaccination coverage against COVID-19 differs widely between countries: in order to address this public health issue, this observational study seeks to understand whether there are any determinants/predictors.
- Trial name
- WORLDCOV (NCT05471635)
- Testing
- COVID-19 Vaccine
- Where
- Italy
- Volunteers
- 205 people, healthy volunteers welcome
- Sponsor
- Alberto Peano
Asthma in Children, Influenza Vaccine
Influenza Vaccine in Children With Asthma
The occurence of influenza can be a factor of imbalance of asthma. Asthma patients are recommended for annual influenza vaccination .
- Conditions
- Asthma in Children, Influenza Vaccine, Immunization Coverage
- Trial name
- VAGA (NCT04086628)
- Where
- France
- Volunteers
- 500 people
- Sponsor
- Central Hospital, Nancy, France
Vaccination, Elderly
Epidemiological Study on the Vaccination Coverage of the Population Aged 75 Years and Over in Picardy. According to the Study of 200 Patients Followed by General Practitioners of the Somme in 2016.
In France, the vaccination coverage of seniors is clearly deficient. It seems to be a cultural specificity, dating back more than 100 years, and which does not exist in Scandinavia, nor in much of the Anglo-Saxon world.
- Trial name
- PICARVAC (NCT03132844)
- Testing
- Analysis records of patients over 75 years of age
- Where
- France
- Volunteers
- 200 people
- Sponsor
- Centre Hospitalier Universitaire, Amiens
Streptococcus Pneumoniae Infection
Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk.
In France, Streptococcus pneumoniae is the leading agent bacterial involved in community lung disease and meningitis. The frequency of these infections and their mortality increase significantly in those at risk such as patients…
- Trial name
- OPTIVACC (NCT05060146)
- Testing
- Structured medico-pharmaceutical collaboration
- Where
- 9 sites in France
- Volunteers
- 646 people
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
mHealth Intervention, SMS
mHealth Intervention for Improving Vaccination Coverage in Bangladesh
Noncompliance and delay in vaccination have caused millions of preventable deaths worldwide particularly in low-and middle-income countries (LMICs).
- Trial name
- NCT07510971
- Testing
- Automated voice reminders with behavior change messages, Text with behavior change message, Control
- Volunteers
- 7,800 people
- Sponsor
- Japan Institute for Health Secutiry
Vaccination
P3+ Intervention Phase
This study will address vaccine uptake both for pregnant women and for their children, through 20 months of age, to test the hypothesis that exposure to the P3+ intervention package will increase the likelihood a pregnant woman…
- Trial name
- NCT02898688
- Testing
- Control Site, Intervention Site, Patient-level Control Group
- Where
- 23 sites in United States
- Volunteers
- 2,200 people, healthy volunteers welcome
- Sponsor
- Emory University